SGI-DNA Launches Gibson Assembly® RapidAMP™ Technology for its BioXp™ Gene Builder

DNA synthesis

Home » Emerging technologies » DNA synthesis

DNA Script to Open U.S. Office in South San Francisco to Support Commercialization of the Company’s Industry-Leading Enzymatic Synthesis Technology

The company also names Dr. Patrick Eimerman Global Head of Marketing and Dr. John Luckey Vice President for Product Development November 05, 2019 01:55 PM Eastern Standard Time PARIS–(BUSINESS WIRE)–DNA...

Evonetix

Evonetix expands facilities and relocates to central Cambridge, UK

Twist Bioscience Showcases New Innovation Lab at SynBioBeta 2019

— Previews Disruptive Gene Pools Product that Includes up to 180,000 Genes for Drug Discovery, Protein Screening and More, at $0.04 per Base Pair – — Silicon-based DNA Synthesis Platform Continues to Enable...

Molecular Assemblies Announces $12.2 M Series A Financing to Advance Enzymatic DNA Synthesis for Life Sciences and Data Storage

Emily Leproust

Why This Synthetic Biology Stock Has Doubled Since IPO

DNA

DNA spells tomorrow: how DNA tech will impact our world

GenScript Partners with Harvard University to Develop Ultra-safe Cells Resistant to Natural Viruses

OriCiro Genomics

Revolutionizing large-size DNA amplification: A Q&A with OriCiro Genomics’ Seiji Hirasaki

Dr Roux

Pasteur vs Possibility – the ever-changing face of the laboratory

SGI-DNA Secures $25 Million Series A Financing to Support Commercial Launch

DNA

Synthetic biology’s Lego kit: Brought to you by Arzeda, TeselaGen, Twist Bioscience, and Labcyte

Ranomics Launches Q-Strands DNA Fragment

SGI-DNA Launches Multi-Tile Assembly Cloning (MTAC) Application for its BioXp™ 3200 System

Twist Bioscience

How Twist Bioscience doubled its stock price in nine months

IDT launches oPools™ Oligo Pools – the longest, highest fidelity, and ready-to-use custom oligo pools on the market